In a report released today, Bradley Canino from Stifel Nicolaus maintained a Buy rating on Oric Pharmaceuticals (ORIC – Research Report), with ...

In a report released today, Bradley Canino from Stifel Nicolaus maintained a Hold rating ... focusing on stocks such as Blueprint Medicines, Kura Oncology, and ALX Oncology Holdings.

Cohu (NASDAQ:COHU – Free Report) had its target price reduced by Stifel Nicolaus from $40.00 to $35.00 in a research note ...

Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire & Co., LLC business divisions ...

What should I know about this firm? Stifel, Nicolaus & Co. Inc. offers investment advising services that let individuals choose the level of control they have over their portfolio. Everyday ...

CAMBRIDGE, MA—Christina Rossi, the Chief Operating Officer of Blueprint Medicines Corp (NASDAQ ... Analysts from Stifel, JPMorgan, and Needham provided positive outlooks on the company's ...

Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire & Co., LLC business divisions ...